focus -WSS

focus

author：explore 2025-09-07 00:14:40 - browse：67

Medical personnel wearing gloves adjust IV bags displayed on a conveyor belt. -- health policy coverage from STAT — Civica Rx is considering a move into chemotherapies amid drug shortages. Adobe

WASHINGTON — A nonprofit formed by hospitals to deal with drug shortages is considering a move into chemotherapies.

Frustrated by drug shortages and the price spikes that typically ensue, executives from large hospital systems launched the nonprofit Civica Rx to deal with the problem in September 2018. Months later, the publicly traded group purchasing organization Premier created a subsidiary, ProvideGx, with the same aim.

Although shortages are not new, the number of drugs in short supply has grown steadily for about two years. Shortages also have become more difficult to predict and are affecting drugs that are more critical.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： Measles policy set amid Florida outbreak alarms vaccine proponents

Wikipedia

WSS

Colorectal cancer study finds potential in overlooked immune cell

As AI regulations shape up, health tech startups beg for clarity

New CMS data security rules will hurt Medicare, Medicaid research

Researchers tackle phage therapy hurdles for wider adoption

Liquid biopsy for lung cancer is launched by Delfi

As AI regulations shape up, health tech startups beg for clarity

hotspot

focus

hotspot

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Surprise medical billing ban raises prices elsewhere

23andMe had bad news about my health. I wish a person had delivered it

A Q&A with the global head of Boehringer Ingelheim's innovation unit

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Readout Newsletter: Bayer, Rapt Therapeutics, Sanofi shortage

The cancer drug shortage isn’t new — and neither are the solutions

Ring Therapeutics, a Flagship gene therapy startup, lays off 20% of staff

In Memoriam: Notable people who died in 2023

FDA authorizes Novavax’s updated Covid

explore

Senate panel eyes new effort on drug shortages

In $4.8 billion deal, Bristol Myers Squibb to buy cancer player Mirati

Elevance, SCAN deals highlight health insurer acquisition scrutiny

FDA panel signals lack of confidence in Amgen cancer drug data

Liquid biopsy for lung cancer is launched by Delfi

Was Amgen transparent enough on FDA's concern on cancer drug?

focus

Wikipedia

focus

hotspot